These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19740098)

  • 1. Genetics of platelet reactivity in normal, healthy individuals.
    Kunicki TJ; Williams SA; Salomon DR; Harrison P; Crisler P; Nakagawa P; Mondala TS; Head SR; Nugent DJ
    J Thromb Haemost; 2009 Dec; 7(12):2116-22. PubMed ID: 19740098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired platelet function among platelet donors.
    Jilma-Stohlawetz P; Hergovich N; Homoncik M; Dzirlo L; Horvath M; Janisiw M; Panzer S; Jilma B
    Thromb Haemost; 2001 Sep; 86(3):880-6. PubMed ID: 11583322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
    Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
    Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
    Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
    Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
    Goto S; Tamura N; Eto K; Ikeda Y; Handa S
    Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
    Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
    Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variations in platelet glycoproteins: pharmacogenomic implications.
    Quinn MJ; Topol EJ
    Pharmacogenomics; 2001 Nov; 2(4):341-52. PubMed ID: 11722284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
    Wadanoli M; Sako D; Shaw GD; Schaub RG; Wang Q; Tchernychev B; Xu J; Porter TJ; Huang Q
    Thromb Haemost; 2007 Aug; 98(2):397-405. PubMed ID: 17721623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA-200).
    Geevar T; Dave RG; Mathews NS; Kumar S; Mammen JJ; Vijayan R; Aboobacker FN; Abraham A; Srivastava A; Nair SC
    Int J Lab Hematol; 2022 Jun; 44(3):603-609. PubMed ID: 34986515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.
    Boncler MA; Golanski J; Paczuski R; Watala C
    J Mol Med (Berl); 2002 Dec; 80(12):796-801. PubMed ID: 12483465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
    Flood VH; Gill JC; Morateck PA; Christopherson PA; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
    Blood; 2011 Feb; 117(6):e67-74. PubMed ID: 21148813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
    Meskal A; Vertessen F; Van der Planken M; Berneman ZN
    Ann Hematol; 1999 Sep; 78(9):426-30. PubMed ID: 10525831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor.
    Chakroun T; Gerotziafas G; Robert F; Lecrubier C; Samama MM; Hatmi M; Elalamy I
    Br J Haematol; 2004 Jan; 124(1):80-5. PubMed ID: 14675411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?
    Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M
    Platelets; 2010; 21(2):101-11. PubMed ID: 20063990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation.
    Oury C; Sticker E; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
    J Biol Chem; 2004 Jun; 279(25):26266-73. PubMed ID: 15087444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.